De­men­tia Dis­cov­ery Fund clos­es $350M, re­cruits Cel­gene ex­ec as CEO; Ex-Lazard banker Ian Woo joins C-Bridge and Ever­est

→ With a fresh $60 mil­lion in­vest­ment from US AARP, the De­men­tia Dis­cov­ery Fund has of­fi­cial­ly closed its $350 mil­lion fundrais­ing round. The to­tal sur­passed the group’s ini­tial tar­get of $200 mil­lion. The DDF says it’s the first and largest fund ded­i­cat­ed to de­men­tia, in­clud­ing Alzheimer’s dis­ease. The fund is man­aged by SV Health and was formed with col­lab­o­ra­tion from Bio­gen, Eli Lil­ly, GSK, J&J, Ot­su­ka (As­tex), Pfiz­er and Take­da, the UK De­part­ment of Health and So­cial Care and the char­i­ty Alzheimer’s Re­search UK. Since the group’s launch in 2015, its made 16 in­vest­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER